Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study.
There is a lack of consistently linked loci influencing blood pressure and hypertension status, and this may be because of genetic or phenotypic heterogeneity. We hypothesize that stratification of subjects by response to antihypertensive drug groups could be used to stringently define subsets that...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2006
|
| _version_ | 1797050489206996992 |
|---|---|
| author | Padmanabhan, S Wallace, C Munroe, P Dobson, R Brown, M Samani, N Clayton, D Farrall, M Webster, J Lathrop, M Caulfield, M Dominiczak, A Connell, J |
| author_facet | Padmanabhan, S Wallace, C Munroe, P Dobson, R Brown, M Samani, N Clayton, D Farrall, M Webster, J Lathrop, M Caulfield, M Dominiczak, A Connell, J |
| author_sort | Padmanabhan, S |
| collection | OXFORD |
| description | There is a lack of consistently linked loci influencing blood pressure and hypertension status, and this may be because of genetic or phenotypic heterogeneity. We hypothesize that stratification of subjects by response to antihypertensive drug groups could be used to stringently define subsets that will have reduced genetic and etiologic heterogeneity, by partitioning contrasting mechanisms of hypertension and, thus, enhancing gene finding. We investigated the British Genetics of Hypertension Study population, which is composed of 2142 severely hypertensive white affected sibling pairs. Nonresponse to antihypertensive therapy was defined as an on-treatment blood pressure of >140/90 mm Hg or a difference between prediagnosis and on-treatment blood pressure of <20 mm Hg. Of the nonresponders, there were 89 sibling pairs (AB) who were both on antihypertensive therapy that inhibit the renin-angiotensin system (angiotensin-converting enzyme inhibitors, angiotensin II type-1 receptor blockers, or beta-blockers), and 76 sibling pairs (CD) who were both on drugs that do not (calcium channel blockers or diuretics). Nonparametric linkage analysis carried out using markers from a 10-cM genome scan and additional "grid tightening" markers showed significant linkage in the AB group on chromosome 2p (logarithm of odds=4.84 at 90.68 Kosambi cM) and suggestive linkage for the CD group on chromosome 10q (logarithm of odds=2.83 at 125.96 Kosambi cM). The AB linkage locus attained genomewide significance after simulation using 10,000 replicates (P=0.005). This locus may contain a gene for the salt-sensitive form of hypertension and/or a pharmacogenetic locus affecting drug response. We have demonstrated for the first time identification of a significant locus by partitioning different pathways of hypertension using drug response. |
| first_indexed | 2024-03-06T18:05:55Z |
| format | Journal article |
| id | oxford-uuid:016c8db3-5007-4a0b-b7f0-d91bd18f9a70 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:05:55Z |
| publishDate | 2006 |
| record_format | dspace |
| spelling | oxford-uuid:016c8db3-5007-4a0b-b7f0-d91bd18f9a702022-03-26T08:34:53ZChromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:016c8db3-5007-4a0b-b7f0-d91bd18f9a70EnglishSymplectic Elements at Oxford2006Padmanabhan, SWallace, CMunroe, PDobson, RBrown, MSamani, NClayton, DFarrall, MWebster, JLathrop, MCaulfield, MDominiczak, AConnell, JThere is a lack of consistently linked loci influencing blood pressure and hypertension status, and this may be because of genetic or phenotypic heterogeneity. We hypothesize that stratification of subjects by response to antihypertensive drug groups could be used to stringently define subsets that will have reduced genetic and etiologic heterogeneity, by partitioning contrasting mechanisms of hypertension and, thus, enhancing gene finding. We investigated the British Genetics of Hypertension Study population, which is composed of 2142 severely hypertensive white affected sibling pairs. Nonresponse to antihypertensive therapy was defined as an on-treatment blood pressure of >140/90 mm Hg or a difference between prediagnosis and on-treatment blood pressure of <20 mm Hg. Of the nonresponders, there were 89 sibling pairs (AB) who were both on antihypertensive therapy that inhibit the renin-angiotensin system (angiotensin-converting enzyme inhibitors, angiotensin II type-1 receptor blockers, or beta-blockers), and 76 sibling pairs (CD) who were both on drugs that do not (calcium channel blockers or diuretics). Nonparametric linkage analysis carried out using markers from a 10-cM genome scan and additional "grid tightening" markers showed significant linkage in the AB group on chromosome 2p (logarithm of odds=4.84 at 90.68 Kosambi cM) and suggestive linkage for the CD group on chromosome 10q (logarithm of odds=2.83 at 125.96 Kosambi cM). The AB linkage locus attained genomewide significance after simulation using 10,000 replicates (P=0.005). This locus may contain a gene for the salt-sensitive form of hypertension and/or a pharmacogenetic locus affecting drug response. We have demonstrated for the first time identification of a significant locus by partitioning different pathways of hypertension using drug response. |
| spellingShingle | Padmanabhan, S Wallace, C Munroe, P Dobson, R Brown, M Samani, N Clayton, D Farrall, M Webster, J Lathrop, M Caulfield, M Dominiczak, A Connell, J Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study. |
| title | Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study. |
| title_full | Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study. |
| title_fullStr | Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study. |
| title_full_unstemmed | Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study. |
| title_short | Chromosome 2p shows significant linkage to antihypertensive response in the British Genetics of Hypertension Study. |
| title_sort | chromosome 2p shows significant linkage to antihypertensive response in the british genetics of hypertension study |
| work_keys_str_mv | AT padmanabhans chromosome2pshowssignificantlinkagetoantihypertensiveresponseinthebritishgeneticsofhypertensionstudy AT wallacec chromosome2pshowssignificantlinkagetoantihypertensiveresponseinthebritishgeneticsofhypertensionstudy AT munroep chromosome2pshowssignificantlinkagetoantihypertensiveresponseinthebritishgeneticsofhypertensionstudy AT dobsonr chromosome2pshowssignificantlinkagetoantihypertensiveresponseinthebritishgeneticsofhypertensionstudy AT brownm chromosome2pshowssignificantlinkagetoantihypertensiveresponseinthebritishgeneticsofhypertensionstudy AT samanin chromosome2pshowssignificantlinkagetoantihypertensiveresponseinthebritishgeneticsofhypertensionstudy AT claytond chromosome2pshowssignificantlinkagetoantihypertensiveresponseinthebritishgeneticsofhypertensionstudy AT farrallm chromosome2pshowssignificantlinkagetoantihypertensiveresponseinthebritishgeneticsofhypertensionstudy AT websterj chromosome2pshowssignificantlinkagetoantihypertensiveresponseinthebritishgeneticsofhypertensionstudy AT lathropm chromosome2pshowssignificantlinkagetoantihypertensiveresponseinthebritishgeneticsofhypertensionstudy AT caulfieldm chromosome2pshowssignificantlinkagetoantihypertensiveresponseinthebritishgeneticsofhypertensionstudy AT dominiczaka chromosome2pshowssignificantlinkagetoantihypertensiveresponseinthebritishgeneticsofhypertensionstudy AT connellj chromosome2pshowssignificantlinkagetoantihypertensiveresponseinthebritishgeneticsofhypertensionstudy |